3-(4-(1H-imidazol-1-ylmethyl)phenyl)-2-propenoic acid,
4-(1-imidazoylmethyl)cinnamic acid,
OKY 046,
OKY-046,
ozagrel,
ozagrel, monohydrochloride,
ozagrel, monohydrochloride, (E)-isomer,
sodium ozagrel,
Ozagrel sodium,
130952-46-4,
189224-26-8,
Sodium ozagrel,
Cataclot,
Xanbon,
Ozagrel (sodium),
UNII-4X5577N3ET,
4X5577N3ET,
Sodium (E)-3-(4-((1H-imidazol-1-yl)methyl)phenyl)acrylate,
C13H11N2NaO2,
Sodium 3-(4-((1H-imidazol-1-yl)methyl)phenyl)acrylate,
Athrombone,
Kadenin,
KCT-0809,
Ozagrel sodium [JAN],
Ozagrel sodium salt [MI],
Ozagrel sodium [WHO-DD],
XanbonS,
KW-01,
Ozapen (TN),
OKY-046 sodium,
Ozagrel sodium (JP17),
sodium,3-[4-(imidazol-1-ylmethyl)phenyl]prop-2-enoate,
SCHEMBL3093220,
HY-B0428A,
DTXSID50172327,
NCNYJCOBUTXCBR-IPZCTEOASA-M,
BCP12393,
5620AA,
2-Propenoic acid, 3-(4-(1H-imidazol-1-ylmethyl)phenyl)-, sodium salt, (E)-,
AKOS015895382,
AKOS015967214,
AKOS025149474,
API0003727,
CS-3808,
EBD3040181,
2-Propenoic acid, 3-(4-(1H-imidazol-1-ylmethyl)phenyl)-, sodium salt (1:1), (2E)-,
2-Propenoic acid, 3-(4-(1H-imidazol-1-ylmethyl)phenyl)-, sodium salt, (2E)-,
AC-15516,
AN-30446,
AS-12150,
LS-54122,
AX8146592,
RT-014881,
TC-157247,
GD95350000,
D01684,
M-1601,
C-15413,
I06-0629,
I14-8283,
sodium (E)-3-[4-(imidazol-1-ylmethyl)phenyl]prop-2-enoate,
(2E)-3-[4-(1H-Imidazol-1-ylmethyl)phenyl]-2-propenoic acid sodium salt,
2-Propenoic acid, 3-[4-(1H-imidazol-1-ylmethyl)phenyl]-, sodium salt (1:1),
2-Propenoic acid, 3-[4-(1H-imidazol-1-ylmethyl)phenyl]-, sodium salt,(2E)-,
2-Propenoic acid,3-[4-(1H-imidazol-1-ylmethyl)phenyl]-, sodium salt (1:1), (2E)-,
SODIUM OZAGREL; OZAGREL SODIUM CP; OZAGRELSODIUMC13H11N2NAO2; 4-(1H-IMIDAZOL-1-YLMETHYL)CINNAMIC ACID SODIUM SALT,
Ozagrelsodium,
Ozagrel Sodium;,
ACN-048762,
CID5282441,
CS-O-02040,